The Rising Incidences Of Seasonal Influenza Drive Growth In The Influenza Vaccine Market Driving Market Acceleration in the Influenza Vaccines Industry, 2025

Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.

How Large Will the Influenza Vaccines Market Size By 2025?
The value of the influenza vaccines market has shown significant expansion in the past few years. It's expected to grow from its $7.35 billion stature in 2024, to reach a size of $7.9 billion in 2025, indicating a compound annual growth rate (CAGR) of 7.5%. Factors such as pandemic readiness, public health measures, effectiveness studies of the vaccine, recommendations from healthcare professionals, and worldwide monitoring of influenza can be accredited for the growth observed during the historical period.

How Big Is the Influenza Vaccines Market Size Expected to Grow by 2029?
The market size for influenza vaccines is predicted to experience robust expansion in the following few years, reaching $11.02 billion in 2029, with a Compound Annual Growth Rate (CAGR) of 8.7%. Factors contributing to the growth during the prediction period include climate and environmental influences, advancements in healthcare accessibility, the emergence of novel influenza strains, and innovations in adjuvants and delivery systems as well as increased healthcare expenditure. Observations for the forecast period point towards a broader usage of mRNA vaccine technology, a concentration on pediatric immunization, strategies for controlling seasonal influenza, increased vaccination rates in developing countries, and personalized vaccination strategies.

View the full report here:
https://www.thebusinessresearchcompany.com/report/influenza-vaccines-global-market-report

Which Key Market Drivers Powering Influenza Vaccines Market Expansion and Growth?
An increase in seasonal flu cases is anticipated to boost the influenza vaccine market's expansion. Seasonal flu is a respiratory disease caused by influenza viruses that circulate and cause infections at specific times of the year, primarily during colder months. The shift is attributed to factors including antigenic drift, susceptibility of the population, environmental aspects, partial vaccine coverage, and the lack of universal inoculation. Influenza vaccines serve to decrease the instances of seasonal flu by offering immunity against the virus strains in circulation. For instance, the US government-run Centers for Disease Control and Prevention (CDC) reported in November 2023 that around 31 million illnesses, 14 million medical consultations, 360,000 hospital admissions, and 21,000 deaths were related to the flu during the 2022-2023 flu season. Therefore, the escalating numbers of influenza seasons are propelling the expansion of the influenza vaccines market.

Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=11935&type=smp

Which Fast-Growing Trends Are Poised to Disrupt the Influenza Vaccines Market?
The use of cutting-edge vaccine production technologies is a significant trend emerging in the influenza vaccine market. To maintain their market presence, companies engaged in the influenza vaccine sector are utilizing sophisticated vaccine production methodologies. For example, in January 2023, a pioneer in the field of pharmaceuticals and biotechnology from the UK, GlaxoSmithKline PLC., launched a novel MAPS - Multiple Antigen Presenting System for vaccine creation. This innovative approach is revolutionizing the way vaccines are produced to combat bacterial and viral threats. This technology proves particularly beneficial in the rapid development of vaccines needed in response to an epidemic or pandemic outbreak.

What Are the Emerging Segments in the Influenza Vaccines Market?
The influenza vaccines market covered in this report is segmented -

1) By Vaccine Type: Inactivated, Live Attenuated
2) By Valency: Quadrivalent, Trivalent
3) By Route Of Administration: Injection, Nasal Spray
4) By Age Group: Pediatric, Adult
5) By Distribution Channel: Hospitals And Pharmacies, Government And Institutional Supply, Other Distribution Channels

Subsegments:
1) By Inactivated: Trivalent Inactivated Vaccines (TIV), Quadrivalent Inactivated Vaccines (QIV)
2) By Live Attenuated: Live Attenuated Influenza Vaccines (LAIV), Quadrivalent Live Attenuated Influenza Vaccines (QLAIV)

Tailor your insights and customize the full report here:
https://www.thebusinessresearchcompany.com/customise?id=11935&type=smp

Who Are the Global Leaders in the Influenza Vaccines Market?
Major companies operating in the influenza vaccines market include Pfizer Inc., F. Hoffmann-La Roche Ltd., Merck & Co. Inc., Novartis AG, Sanofi-Aventis LLC., AstraZeneca PLC, GlaxoSmithKline plc., Serum Institute of India Private Limited, Takeda Pharmaceutical Company Limited, Moderna Inc., Viatris Inc., CSL Limited, Seqirus Inc., Daiichi Sankyo Company Limited, China National Pharmaceutical Group Corporation, Shanghai Fosun Pharmaceutical Group Co. Ltd., Mitsubishi Tanabe Pharma Corporation, Shionogi & Co. Ltd., Liaoning Cheng Da Biotechnology Co. Ltd., Novavax AB, Sinovac Biotech Co. Ltd., Green Cross Corporation, Emergent BioSolutions Inc., Walvax Biotechnology Co. Ltd., Hualan Biological Engineering Inc., Valneva SE, Bharat Biotech International Limited, Vaxess Technologies Inc., Osivax, Gamma Vaccines Pty. Ltd.

Which are the Top Profitable Regional Markets for the Influenza Vaccines Industry?
North America was the largest region in the influenza vaccines market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the influenza vaccines market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Purchase the full report today:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=11935

This Report Supports:
1. Business Leaders & Investors - To identify growth opportunities, assess risks, and guide strategic decisions.
2. Manufacturers & Suppliers - To understand market trends, customer demand, and competitive positioning.
3. Policy Makers & Regulators - To track industry developments and align regulatory frameworks.
4. Consultants & Analysts - To support market entry, expansion strategies, and client advisory work.

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Europe: +44 7882 955267,
Asia: +91 88972 63534,
Americas: +1 310-496-7795 or
Email: mailto:info@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.